Evidence map›Paper›PMID 37271162›Full record

ArticleThe Lancet. Global health2023

Neural tube defects as a cause of death among stillbirths, infants, and children younger than 5 years in sub-Saharan Africa and southeast Asia: an analysis of the CHAMPS network.

Lola Madrid, Kartavya J Vyas, Vijaya Kancherla, Haleluya Leulseged, Parminder S Suchdev, Quique Bassat, Samba O Sow, Shams El Arifeen, Shabir A Madhi, Dickens Onyango and 31 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. MaternalGenes · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Clinical and epidemiological profile of neonatal neural tube defects in Turkey: a nationwide retrospective cohort analysis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
  13. Article
  14. Article
  15. Timeliness of surgical repair among infants with myelomeningocele in a tertiary care hospital in Addis Ababa, Ethiopia.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 18 institutions in 10 countries.

Lola MadridDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia. Electronic address: lola.madrid-castillo@lshtm.ac.uk.
Kartavya J VyasEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Vijaya KancherlaRollins School of Public Health, Emory University, Atlanta, GA, USA.
Haleluya LeulsegedCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Parminder S SuchdevEmory Global Health Institute, Emory University, Atlanta, GA, USA; Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Quique BassatISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; ICREA, Barcelona, Spain; Paediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Samba O SowCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Shams El ArifeenInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Dickens OnyangoKisumu County Department of Health, Kisumu, Kenya.
Ikechukwu OgbuanuCrown Agents, Freetown, Sierra Leone.
J Anthony G ScottDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Dianna BlauCenter for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Inacio MandomandoCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Instituto Nacional de Saúde, Maputo, Mozambique.
Adama M KeitaCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Emily S GurleyDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Sana MahtabSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Victor AkeloUS Centers for Disease Control and Prevention Kenya, Kisumu, Kenya.
Sulaiman SannohCrown Agents, Freetown, Sierra Leone.
Yenenesh TilahunCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Rosauro VaroISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Uma OnwuchekwaDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Afruna RahmanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Yasmin AdamSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Richard OmoreKisumu County Department of Health, Kisumu, Kenya.
Sandra LakoCrown Agents, Freetown, Sierra Leone.
Elisio XerindaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Kazi Munisul IslamInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Amy WiseSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Beth A Tippet-BarrUS Centers for Disease Control and Prevention Kenya, Kisumu, Kenya.
Erick KalumaCrown Agents, Freetown, Sierra Leone.
Sara AjanovicISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Karen L KotloffDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Mohammad Zahid HossainInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Portia MutevedziSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Milagritos D TapiaDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Emily RogenaDepartment of Pathology, School of Medicine, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Francis MosesMinistry of Health and Sanitation, Freetown, Sierra Leone.
Cynthia G WhitneyEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
CHAMPS Consortium
International Centre for Diarrhoeal Disease Research · BDUniversity of Maryland, Baltimore · USHaramaya University · ETCentre Pour le Développement des Vaccins-Mali · MLGreat Lakes University of Kisumu · KEEmory University · USManhiça Health Research Centre · MZSouth African Medical Research Council · ZAUniversity of the Witwatersrand · ZACenter for Global Health · USCenters for Disease Control and Prevention · KEJomo Kenyatta University of Agriculture and Technology · KELondon School of Hygiene & Tropical Medicine · GBInstitució Catalana de Recerca i Estudis Avançats · ESInstituto Nacional de Saúde · MZJohns Hopkins University · USMinistry of Health and Sanitation · SLUniversitat de Barcelona · ES

Funding

Ethiopia Global Infectious Diseases Training ProgramD43TW011386 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI BERHANE, YEMANE, FAWZI, WAFAIE W · 2020 to 2024
$1.2M
Wellcome Trust
6 · The paper itself

Abstract

backgroundNeural tube defects are common birth defects resulting in severe morbidity and mortality; they can largely be prevented with periconceptional maternal intake of folic acid. Understanding the occurrence of neural tube defects and their contribution to mortality in settings where their burden is highest could inform prevention and health-care policy. We aimed to estimate the mortality attributed to neural tube defects in seven countries in sub-Saharan Africa and southeast Asia.

methodsThis analysis used data from the Child Health and Mortality Prevention Surveillance (CHAMPS) network and health and demographic surveillance systems from South Africa, Mozambique, Bangladesh, Kenya, Mali, Ethiopia, and Sierra Leone. All stillbirths and infants and children younger than 5 years who died, who were enrolled in CHAMPS, whose families consented to post-mortem minimally invasive tissue sampling (MITS) between Jan 1, 2017, and Dec 31, 2021, and who were assigned a cause of death by a determination of cause of death panel as of May 24, 2022, were included in this analysis, regardless the cause of death. MITS and advanced diagnostic methods were used to describe the frequency and characteristics of neural tube defects among eligible deaths, identify risk factors, and estimate the mortality fraction and mortality rate (per 10 000 births) by CHAMPS site.

findingsCauses of death were determined for 3232 stillbirths, infants, and children younger than 5 years, of whom 69 (2%) died with a neural tube defect. Most deaths with a neural tube defect were stillbirths (51 [74%]); 46 (67%) were neural tube defects incompatible with life (ie, anencephaly, craniorachischisis, or iniencephaly) and 22 (32%) were spina bifida. Deaths with a neural tube defect were more common in Ethiopia (adjusted odds ratio 8·09 [95% CI 2·84-23·02]), among female individuals (4·40 [2·44-7·93]), and among those whose mothers had no antenatal care (2·48 [1·12-5·51]). Ethiopia had the highest adjusted mortality fraction of deaths with neural tube defects (7·5% [6·7-8·4]) and the highest adjusted mortality rate attributed to neural tube defects (104·0 per 10 000 births [92·9-116·4]), 4-23 times greater than in any other site.

interpretationCHAMPS identified neural tube defects, a largely preventable condition, as a common cause of death among stillbirths and neonatal deaths, especially in Ethiopia. Implementing interventions such as mandatory folic acid fortification could reduce mortality due to neural tube defects.

fundingBill & Melinda Gates Foundation.

Indexed as

Neural Tube DefectsStillbirthAsia, SoutheasternCause of DeathChildEthiopiaFemaleFolic AcidHumansInfantInfant, NewbornMothersPregnancyFolic Acid

Identifiers

PMID37271162
PMCPMC10282076
OpenAlexW4379055713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.